3 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
Follow BOTOX®: new trials by email Literature Review of BOTOX® trials Research Report on BOTOX®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17) BOTOX® - Urinary Incontinence, Urinary Bladder | Phase 3 | Terminated | Allergan | 56 | 2014-05-23 | 2022-12-28 |
| OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity onabotulinumtoxinA, placebo (normal saline) - Muscle Spasticity, Stroke | Phase 3 | Terminated | Allergan | 53 | 2014-05-01 | 2017-04-12 |
| Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder botulinum toxin Type A, Normal Saline (Placebo) - Overactive Bladder | Phase 3 | Terminated | Allergan | 41 | 2007-06-01 | 2014-01-24 |
Muscle Spasticity (1) · Stroke (1) · Urinary Bladder, Overactive (1) · Urinary Incontinence (1)
Allergan (3)
Canada (3) · United States (3) · Australia (2) · Belgium (1) · Czechia (1) · France (1) · Germany (1) · India (1) · Italy (1) · Netherlands (1) · Norway (1) · Poland (1) · South Africa (1) · United Kingdom (1)
2014 (1)